Articles

The purchase boosts the parties’ sterile liquid manufacturing capabilities.

Adragos Pharma, Prange Group Acquires Fresenius Kabi Plant

The latest news for pharma industry insiders.

Pharma Pulse 3/4/24: Local Pharmacies on the Brink, People in MA Plans Experienced Delays in Accessing Care & more

A JAMA Network Open study dives into how the utilization of a digital patient portal changed during the COVID-19 pandemic, while also exploring ways that multimorbidity and socioeconomic disparities affected those statistics. 

Examining the Impact of the COVID-19 Pandemic on Patient Portal Use

With its aims to protect healthcare consumers against the dangers of counterfeit, contaminated, stolen or otherwise harmful drugs, the DSCSA represents a significant step forward in securing the pharmaceutical supply chain. 

Streamlining for Safety: Navigating Changes and Trends in the Pharmaceutical Supply Chain Post-DSCSA

The offering reportedly helps avoid product quarantine.

Systech Introduces Solution for Managing Pharma Supply Chain Exceptions

A cohort study investigates a potential correlation between the stresses caused by Mother Nature and mental health. 

The Connection Between Natural Disasters and the Rise in Psychotropic Medication Prescriptions

IPX203—an oral formulation carbidopa/levodopa extended-release capsules —would expand Zambon’s neurology portfolio. 


 Amneal, Zambon Biotech Enter Exclusive European Licensing Agreement for Parkinson’s Disease Medication

Podcasts

Rob Besse offers a breakdown of the third-party logistics (3PL) process, including lessons that these providers have learned coming out of the pandemic.  

A First-Hand Account of 3PLs

Videos

In an interview with Pharma Commerce Associate Editor Don Tracy, Corey Ford, VP, Reimbursement & Policy Insights, Cencora, offers his thoughts on where the Inflation Reduction Act will be five to 10 years from now. 

Cencora's Corey Ford Discusses the Future of the Inflation Reduction Act

A Carrum Health/PWC report surveys benefit managers spanning various self-insured employers in an effort to determine ways to improve the cancer treatment experience, especially from a cost perspective. 

News